Annals of Indian Academy of Neurology
  Users Online: 519 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
ORIGINAL ARTICLE
Year : 2022  |  Volume : 25  |  Issue : 6  |  Page : 1099-1103

Profiling cognitive impairment in mild COVID-19 patients: A case-control study at a secondary healthcare centre in the hilly region of North India


1 Department of Surgery, Military Hospital Shimla, Shimla, Himachal Pradesh, India
2 Department of Medicine, Military Hospital Shimla, Shimla, Himachal Pradesh, India
3 Department of Neurology, SN Medical College, Agra, Uttar Pradesh, India
4 Department of Otorhinolaryngology (ENT), Military Hospital Shimla, Shimla, Himachal Pradesh, India
5 Department of Emergency Medicine, Military Hospital Shimla, Shimla, Himachal Pradesh, India

Correspondence Address:
Himanshu Chhagan Bayad
Department of Otorhinolaryngology (ENT), Military Hospital, Circular Road, Sanjauli, Shimla, Himachal Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.aian_543_22

Rights and Permissions

Context: COVID-19 pandemic continues to be a serious threat to humanity even after the last 2.5 years and multiple reported waves. Post-COVID-19 cognitive impairment has a detrimental effect on the quality of life, education, occupation, psychosocial as well as adaptive functioning and independence. Aims and Objective: Profiling the cognitive impairment in the mild COVID-19 recovered patients. Settings and Design: Interview-based case-control study. Materials and Methods: This study was conducted at a secondary healthcare center in a hilly region of north India. Group A included mild COVID-19 recovered patients and Group B included local non-COVID healthy individuals. Both groups of participants were interviewed using Montreal Cognitive Assessment (MoCA) to identify global and domain-wise cognitive impairment. Statistics Used: Descriptive statistics were used to analyze the demographic and clinical variables. The Chi-square test was used to evaluate these results and statistical analysis was done using the Statistical Package for Social Sciences (version 23) program. Results: A total of 284 individuals were enrolled in our study, equally split into Groups A (cases) and B (controls). No global cognitive decline was found in any participant. However, 40 cases scored low on MoCA. The decrease in domain-wise cognitive function was statistically significant for visuospatial skill/executive function and attention. Conclusion: Our results have demonstrated that there is domain-wise cognitive impairment associated with mild COVID-19 disease. We recommend lowering the threshold of the MoCA to identify the early cognitive impairment and the inclusion of detailed cognitive assessment in post-COVID-19 follow-ups to initiate early cognitive rehabilitation among these patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed333    
    Printed16    
    Emailed0    
    PDF Downloaded22    
    Comments [Add]    

Recommend this journal